Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Calcifediol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 443,847Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    New Clinical Data on OPKO Health™s RAYALDEE Presented at Kidney Week 2023
    New Clinical Data on OPKO Health™s RAYALDEE Presented at Kidney Week 2023

    02 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/02/2772514/0/en/New-Clinical-Data-on-OPKO-Health-s-RAYALDEE-ER-Calcifediol-Presented-at-Kidney-Week-2023.html

    GLOBENEWSWIRE
    02 Nov 2023
    Share Share
    OPKO Health to Present New Clinical Data on Rayaldee at Kidney Week 2023
    OPKO Health to Present New Clinical Data on Rayaldee at Kidney Week 2023

    25 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/25/2766975/0/en/OPKO-Health-to-Present-New-Clinical-Data-on-Rayaldee-ER-Calcifediol-at-Kidney-Week-2023.html

    GLOBENEWSWIRE
    25 Oct 2023
    Share Share
    RAYALDEE Launched in Germany by OPKO Health’s Licensee, VFMCRP
    RAYALDEE Launched in Germany by OPKO Health’s Licensee, VFMCRP

    03 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/03/2378541/0/en/RAYALDEE-Launched-in-Germany-by-OPKO-Health-s-Licensee-VFMCRP.html

    GLOBENEWSWIRE
    03 Feb 2022
    Share Share
    OPKO Health Announces Topline Data from Phase 2 Trial of Rayaldee
    OPKO Health Announces Topline Data from Phase 2 Trial of Rayaldee

    24 Dec 2021

    // TRIALSITENEWS

    https://trialsitenews.com/opko-health-announces-topline-data-from-phase-2-trial-of-rayaldee-in-treating-mild-to-moderate-covid-19-supporting-the-use-of-vitamin-d-repletion-therapy/

    TRIALSITENEWS
    24 Dec 2021
    Share Share
    OPKO Health completes enrollment in phase 2 trial of Rayaldee to treat Covid-19
    OPKO Health completes enrollment in phase 2 trial of Rayaldee to treat Covid-19

    01 Sep 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=142236&sid=2

    PHARMABIZ
    01 Sep 2021
    Share Share
    OPKO Health Completes Enrollment in PII Trial of RAYALDEE for COVID-19 patients
    OPKO Health Completes Enrollment in PII Trial of RAYALDEE for COVID-19 patients

    30 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/30/2288690/0/en/OPKO-Health-Completes-Enrollment-in-Phase-2-Trial-Evaluating-RAYALDEE-as-a-Treatment-for-Symptomatic-COVID-19-Outpatients.html

    GLOBENEWSWIRE
    30 Aug 2021
    Share Share